Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: Possible mediation by endothelin

Journal of Physiology

Volumn 549, Issue 3, 2003, Pages 903-917

  Fang, Ming ^a   Kovács, Katalin J ^a   Fisher, Lauralei L ^a   Larson, Alice A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AMIDE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN 1; EVANS BLUE; LIGAND; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; RECEPTOR BLOCKING AGENT; THROMBIN; AMINO ACID; ENDOTHELIN A RECEPTOR ANTAGONIST; SERYLPHENYLLEUCYLLEUCYLARGINYLASPARTIC ACID; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTE; BINDING SITE; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; EDEMA; HIPPOCAMPUS; HYPERALGESIA; HYPOTHESIS; INTRACELLULAR TRANSPORT; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN TRANSPORT; RECEPTOR BLOCKING; REVIEW; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SPINAL CORD; WRITHING TEST; ADULT; ARTICLE; HOT PLATE TEST; MALE; PAIN ASSESSMENT; TAIL FLICK TEST; VON FREY TEST;

ACETIC ACID; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; BEHAVIOR, ANIMAL; CAPILLARY PERMEABILITY; ENDOTHELINS; EVANS BLUE; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HYPERALGESIA; INDAZOLES; INJECTIONS, INTRAPERITONEAL; MALE; MICE; N-METHYLASPARTATE; NOCICEPTORS; OLIGOPEPTIDES; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; PHYSICAL STIMULATION; PIPERIDINES; REACTION TIME; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; THROMBIN; UREA;

EID: 0038380599     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2002.036384     Document Type: Review

References (68)

1. Aanonsen LM & Wilcox GL (1986). Phencyclidine selectively blocks a spinal action of N-methyl-D-aspartate in mice. Neurosci Lett 67, 191-197.
2. Andrade-Gordon, P, Maryanoff BE, Derian CK, Zhang HC, Addo ME, Darrow AL, Eckardt AJ, Hoekstra WJ, McComsey DF, Oksenberg D, Reynolds EE, Santulli RJ, Scarborough RM, Smith CE & White KB (1999). Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor. Proc Natl Acad Sci U S A 96, 12 257-12 262.
3. Asfaha S, Brusse V, Chapman K, Zochodne DW & Vergnolle N (2002). Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br J Pharmacol 135, 1101-1106.
4. Bjorkman R (1995). Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat. Acta Anesthesiol Scand 103, suppl., 1-44.
5. Boyce S, Wyatt A, Webb JK, O'Donnell R, Mason G, Rigby M, Sirinathsinghji D, Hill RG & Rupniak NM (1999). Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 38, 611-623.
6. Charton JP, Herkert M, Becker CM & Schroder H (1999). Cellular and subcellular localization of the 2B-subunit of the NMDA receptor in the adult rat telencephalon. Brain Res 816, 609-617.
7. Debeir R, Benavides J & Vige X (1996). Dual effects of thrombin and a 14-amino acid peptide agonist of the thrombin receptor on septal cholinergic neurons. Brain Res 708, 159-166.
8. de Garavilla L, Vergnolle N, Young SH, Ennes H, Steinhoff M, Ossovskaya VS, D'Andrea MR, Mayer EA, Wallace JL, Hollenberg MD, Andrade-Gordon P & Bunnett NW (2001). Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol 133, 975-987.
9. Dihanich M, Kaser M, Reinhard E, Cunningham DD & Monard D (1991). Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6, 575-581.
10. Dunah AW, Yasuda RP, Wang YH, Luo J, Davila-Garcia M, Gbadegesin M, Vicini S & Wolfe BB (1996). Regional and ontogenic expression of the NMDA receptor subunit NR2D protein in rat brain using a subunit-specific antibody. J Neurochem 67, 2335-2345.
11. Ehrenreich H, Costa T, Clouse KA, Pluta RM, Ogino Y, Coligan JE & Burd PR (1993). Thrombin is a regulator or astrocytic endothelin-1. Brain Res 600, 201-207.
12. Fang M, Fisher LL, Kovács KJ & Larson AA (2001). Intrathecal injection of thrombin, a serine protease, inhibits NMDA-induced behaviors and hyperalgesia in mice. Soc Neurosci Abstr 27, 57.5.
13. Festoff BW, Smirnova IV, Ma J & Citron BA (1996). Thrombin, its receptor and protease nexin 1, its potent serpin, in the nervous system. Semin Thromb Hemost 22, 267-271.
14. Gingrich MB, Jung CE, Lyuboslavsky P & Traynelis SF (2000). Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci 20, 4582-4595.
15. Giovengo SL, Kitto KF, Kurtz HJ, Velázquez RA & Larson AA (1999). Parenterally administered kainic acid induces a persistent hyperalgesia in the mouse and rat. Pain 83, 347-358.
16. Goebel DJ & Poosch MS (1999). NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A. Brain Res Mol Brain Res 69, 164-170.
17. Gokin AP, Fareed MU, Pan HL, Hans G, Strichartz GR & Davar G (2001). Local injection of endothelin-1 produces pain-like behavior and excitation of nociceptors in rats. J Neurosci 21, 5358-5366.
18. Hamilton JR, Chow JM & Cocks TM (1999). Protease-activated receptor-2 turnover stimulated independently of receptor activation in porcine coronary endothelial cells. Br J Pharmacol 127, 717-622.
19. Hammes SR & Coughlin SR (1999). Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand. Biochemistry 38, 2486-2493.
20. Hasselblatt M, Kamrowski-Kruck H, Jensen N, Schilling L, Kratzin H, Siren AL & Ehrenreich H (1998). ETA and ETB receptor antagonists synergistically increase extracellular endothelin-1 levels in primary rat astrocyte cultures. Brain Res 785, 253-261.
21. Hollenberg MD (1999). Protease-activated receptors: PAR4 and counting: how long is the course? Trends Pharmacol Sci 20, 271-273.
22. Hollenberg MD, Saifeddine M, Al-Ani B & Kawabata A (1997). Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 75, 832-841.
23. Hylden JlK & Wilcox GL (1981). Intrathecal morphine in mice: A new technique. Eur J Pharmacol 76, 313-316.
24. Ihara M, Fukami T, Ishikawa K, Nishikibe M & Yano M (1992). Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 50, 247-255.
25. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Furokoda T, Fukami T, Ozaki S, Nagase T, Nishikibe M & Yano M (1994). Biochemical and pharmcological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A 91, 4892-4896.
26. Kamei J, Hitosugi H, Kawashima N, Misawa M & Kasuya Y (1993). Antinociceptive effects of intrathecally administered endothelin-1 in mice. Neurosci Lett 153, 69-72.
27. 125I] endothelin-1 binding sites in spinal cord and dorsal root ganglia of the rat. Neurosci Lett 133, 117-120.
28. Kawabata A, Kuroda R, Nishikawa H, Asai T, Kataoka K & Taneda M (1999). Enhancement of vascular permeability by specific activation of protease-activated receptor-1 in rat hindpaw: a protective role of endogenous and exogenous nitric oxide. Br J Pharmacol 126, 1856-1862.
29. Kawai N, Kawanishi M, Okauchi M & Nagao S (2001). Effects of hypothermia on thrombin-induced brain edema formation. Brain Res 895, 50-58.
30. Larson AA, Kovács KJ, Cooper JC & Kitto KF (2000). Transient changes in the synthesis of nitric oxide result in long-term as well as short-term changes in acetic acid-induced writhing in mice. Pain 86, 103-111.
31. Laughlin TM, Kitto KF & Wilcox GL (1999). Redox manipulation of NMDA receptors in vivo: alteration of acute pain transmission and dynorphin-induced allodynia. Pain 80, 37-43.
32. Laursen H, Hansen AJ & Sheardown M (1993). Cerebrovascular permeability and brain edema after photochemical infarcts in the rat. Acta Neuropathol (Berl) 86, 378-385.
33. Liu H, Mantyh PW & Basbaum AI (1997). NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 386, 721-724.
34. Liu H, Wang H, Sheng M, Jan LY, Jan YN & Basbaum AI (1994). Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc Natl Acad Sci U S A 91, 8383-8387.
35. Molino M, Blanchard N, Belmonte E, Tarver AP, Abrams C, Hoxie JA, Cerletti C & Brass LF (1995). Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol Chem 270, 11168-11175.
36. Molino M, Woolkalis MJ, Reavey-Cantwell J, Pratico D, Andrade-Gordon P, Barnathan ES & Brass LF (1997). Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment. J Biol Chem 272, 11133-11141.
37. Nagy Z, Kolev K, Csonka E, Vastag M & Machovich R (1998). Perturbation of the integrity of the blood brain barrier by fibrinolytic enzymes. Blood Coagul Fibrinolysis 9, 471-478.
38. Niclou S, Suidan HS, Brown-Luedi M & Monard D (1994). Expression of the thrombin receptor mRNA in rat brain. Cell Mol Biol Res 40, 421-428.
39. Niclou SP, Suidan HS, Pavlik A, Vejsada R & Monard D (1998). Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. Eur J Neurosci 10, 1590-1607.
40. Nikolov R, Semkova I, Maslarova J & Moyanova S (1993). Antinociceptive effect of centrally administered endothelin-1 and endothelin-3 in the mouse. Methods Find Exp Clin Pharmacol 15, 447-453.
41. 125I-endothelin-1 binding sites in the central nervous system. Clin Exp Hypertens A 13, 799-806.
42. O'Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS & Brass LF (2000). Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 275, 13502-13509.
43. Piovezan AP, D'Orleans-Juste P, Tonussi CR & Rae GA (1998). Effects of endothelin-1 on capsaicin-induced nociception in mice. Eur J Pharmacol 351, 15-22.
44. Pomonis JD, Rogers SD, Peters CM, Ghilardi JR & Mantyh PW (2001). Expression and localization of endothelin receptors: implications for the involvement of peripheral glia in nociception. J Neurosci 21, 999-1006.
45. Raffa RB & Jacoby HI (1991). Endothelin-1, -2 and -3 directly and big-endothelin-1 indirectly elicit an abdominal constriction response in mice. Life Sci 48, PL85-90.
46. Renesto P, Si-Tahar M, Moniatte M, Balloy V, van Dorsselaer A, Pidard D & Chignar M (1997). Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, calthepsin G, and proteinase 3: evidence for distinct cleavage sites within the amino-terminal domain of the thrombin receptor. Blood 89, 1944-1953.
47. Rosenblum WI, Nelson GH & Murata S (1995). Protein synthesis and rapid recovery of endothelium-dependent dilation after endothelial injury of pial arterioles. Am J Physiol 268, H512-515.
48. Salzman SK, Acosta R, Beck G, Madden J, Boxer B & Ohlstein EH (1996). Spinal endothelin content is elevated after moderate local trauma in the rat to levels associated with locomotor dysfunction after intrathecal injection. J Neurotrauma 13, 93-101.
49. Saria A & Lundberg JM (1983). Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods 8, 41-49.
50. Shapiro MJ, Trejo J, Zeng D & Coughlin SR (1996). Role of thrombin receptor's cytoplasmic tail in intracellular trafficking. J Biol Chem 271, 32874-32880.
51. Singh PP, Junnarkar AY & VarmA, RK (1987). A test for analgesics: incoordination in writhing mice. Methods Find Exp Clin Pharmacol 9, 9-11.
52. Sprengel R & Seeburg PH (1993). The unique properties of glutamate receptor channels. FEBS Lett 325, 90-94.
53. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, Trevisani M, Hollenberg MD, Wallace JL, Caughey GH, Mitchell SE, Williams LM, Geppetti P, Mayer EA & Bunnett NW (2000). Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6, 151-158.
54. Stoltz JF, Boisseau M, Muller S, Wang X, Legrand S & Labrador MV (1999). Hemorheology and vascular endothelial cells. J Mal Vasc 24, 99-109.
55. Striggow F, Riek M, Breder J, Henrich-Noack P, Reymann KG & Reiser G (2000). The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci USA 97, 2264-2269.
56. Sundstrom E, Whittemore S, Mo LL & Seiger A (1997). Analysis of NMDA receptors in the human spinal cord. Exp Neurol 148, 407-413.
57. Tapparelli C, Metternich R, Ehrhardt C & Cook NS (1993). Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile. Trends Pharmacol Sci 14, 366-376.
58. Tölle TR, Berthele A, Zieglgansberger W, Seeburg PH & Wisden W (1993). The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci 13, 5009-5028.
59. 2+ signalling evoked by the tethered ligand. J Physiol 525, 319-330.
60. 3H]substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse. J Pharmacol Exp Ther 281, 1231-1237.
61. Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton, SJ, Grady EF, Cirino G, Gerard N, Basbaum AI, Andrade-Gordon P, Hollenberg MD & Wallace JL (2001a). Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med 7, 821-826.
62. Vergnolle N, Wallace JL, Bunnett NW & Hollenberg MD (2001b). Proteinase-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 22, 146-152.
63. Weinstein JR, Gold SJ, Cunningham DD & Gall CM (1995). Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci 15, 2906-2919.
64. Westmark R, Noble LJ, Fukuda K, Aihara N & McKenzie, AL (1995). Intrathecal administration of endothelin-1 in the rat: impact on spinal cord blood flow and the blood-spinal cord barrier. Neurosci Lett 192, 173-176.
65. Willis WD (1999). Dorsal root potentials and dorsal root reflexes: a double-edged sword (review). Exp Brain Res 124, 395-421.
66. Yaksh TL, Hua XY, Kalcheva I, Nozaki-Taguchi N & Marsala M (1999). The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci U S A 96, 7680-7686.
67. Yamada T & Nagai Y (1996). Immunohistochemical studies of human tissues with antibody to factor Xa. Histochem J 28, 73-77.
68. Zain J, Huang Y-Q, Feng X, Nierodzik L, Li J-J & Karpatkin S (2000). Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells. Blood 95, 3133-3138.